Nothing Special   »   [go: up one dir, main page]

GB0520578D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0520578D0
GB0520578D0 GB0520578A GB0520578A GB0520578D0 GB 0520578 D0 GB0520578 D0 GB 0520578D0 GB 0520578 A GB0520578 A GB 0520578A GB 0520578 A GB0520578 A GB 0520578A GB 0520578 D0 GB0520578 D0 GB 0520578D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0520578A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0520578A priority Critical patent/GB0520578D0/en
Publication of GB0520578D0 publication Critical patent/GB0520578D0/en
Priority to TW095136996A priority patent/TW200728258A/en
Priority to KR1020087011273A priority patent/KR20080059297A/en
Priority to AT06806111T priority patent/ATE543797T1/en
Priority to NZ567030A priority patent/NZ567030A/en
Priority to ES06806111T priority patent/ES2381686T3/en
Priority to JP2008534911A priority patent/JP5139306B2/en
Priority to BRPI0617189-3A priority patent/BRPI0617189A2/en
Priority to EA200801068A priority patent/EA200801068A1/en
Priority to PCT/EP2006/009732 priority patent/WO2007042240A1/en
Priority to CA002625763A priority patent/CA2625763A1/en
Priority to PE2006001224A priority patent/PE20070495A1/en
Priority to CNA2006800464387A priority patent/CN101326162A/en
Priority to UAA200804636A priority patent/UA93886C2/en
Priority to US11/570,564 priority patent/US7803833B2/en
Priority to EP06806111A priority patent/EP1934176B1/en
Priority to AU2006301471A priority patent/AU2006301471A1/en
Priority to ARP060104440A priority patent/AR057869A1/en
Priority to IL190544A priority patent/IL190544A/en
Priority to ZA200802877A priority patent/ZA200802877B/en
Priority to CR9926A priority patent/CR9926A/en
Priority to NO20082122A priority patent/NO20082122L/en
Priority to US12/850,330 priority patent/US8153623B2/en
Ceased legal-status Critical Current

Links

GB0520578A 2005-10-10 2005-10-10 Novel compounds Ceased GB0520578D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GB0520578A GB0520578D0 (en) 2005-10-10 2005-10-10 Novel compounds
TW095136996A TW200728258A (en) 2005-10-10 2006-10-05 Novel compounds
AU2006301471A AU2006301471A1 (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
CA002625763A CA2625763A1 (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
UAA200804636A UA93886C2 (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
NZ567030A NZ567030A (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
ES06806111T ES2381686T3 (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as sodium channel modulators with voltage opening
JP2008534911A JP5139306B2 (en) 2005-10-10 2006-10-06 Quaternary .ALPHA.-aminocarboxamide derivatives as regulators of voltage-gated sodium channels
BRPI0617189-3A BRPI0617189A2 (en) 2005-10-10 2006-10-06 quarternary alpha-aminocarboxamide derivatives, pharmaceutical composition containing them, preparation process, as well as voltage-dependent sodium channel modulating uses
EA200801068A EA200801068A1 (en) 2005-10-10 2006-10-06 DERIVATIVES OF THE QUARTERLY ALPHA-AMINOCARBOXAMIDE AS MODULATORS OF POTENTIAL-DEPENDENT SODIUM CHANNELS
PCT/EP2006/009732 WO2007042240A1 (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
KR1020087011273A KR20080059297A (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
PE2006001224A PE20070495A1 (en) 2005-10-10 2006-10-06 QUATERNARY COMPOUNDS DERIVED FROM alpha-AMINOCARBOXIAMIDE AS MODULATORS OF SODIUM CHANNELS WITH OPENING BY VOLTAGE
CNA2006800464387A CN101326162A (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
AT06806111T ATE543797T1 (en) 2005-10-10 2006-10-06 QUATERNARY ALPHA-AMINOCARBONIC ACID AMIDE DERIVATIVES AS MODULATORS OF VOLTAGE-DEPENDENT SODIUM CHANNELS
US11/570,564 US7803833B2 (en) 2005-10-10 2006-10-06 Compounds
EP06806111A EP1934176B1 (en) 2005-10-10 2006-10-06 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
ARP060104440A AR057869A1 (en) 2005-10-10 2006-10-09 QUATERNARY COMPOUND OF (ALPHA) -AMINOCARBOXYAMIDE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS TO PREPARE SUCH COMPOUND
IL190544A IL190544A (en) 2005-10-10 2008-03-31 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
ZA200802877A ZA200802877B (en) 2005-10-10 2008-04-02 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
CR9926A CR9926A (en) 2005-10-10 2008-04-25 DERIVATIVES OF ALFA-AMINOCARBOXAMIDE QUATERNARY AS MUDULATORS OF SODIUM CHANNELS WITH VOLTAGE GATE
NO20082122A NO20082122L (en) 2005-10-10 2008-05-06 Quaternary alpha-amino carboxamide derivatives as modulators of voltage outlet sodium channels
US12/850,330 US8153623B2 (en) 2005-10-10 2010-08-04 Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0520578A GB0520578D0 (en) 2005-10-10 2005-10-10 Novel compounds

Publications (1)

Publication Number Publication Date
GB0520578D0 true GB0520578D0 (en) 2005-11-16

Family

ID=35430118

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0520578A Ceased GB0520578D0 (en) 2005-10-10 2005-10-10 Novel compounds

Country Status (4)

Country Link
CN (1) CN101326162A (en)
GB (1) GB0520578D0 (en)
UA (1) UA93886C2 (en)
ZA (1) ZA200802877B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201139406A (en) * 2010-01-14 2011-11-16 Glaxo Group Ltd Voltage-gated sodium channel blockers
GB201122113D0 (en) * 2011-12-22 2012-02-01 Convergence Pharmaceuticals Novel compounds
GB201209015D0 (en) * 2012-05-22 2012-07-04 Convergence Pharmaceuticals Novel compounds
AU2018347349A1 (en) 2017-10-10 2020-04-23 Biogen Inc. Process for preparing spiro derivatives

Also Published As

Publication number Publication date
ZA200802877B (en) 2008-12-31
CN101326162A (en) 2008-12-17
UA93886C2 (en) 2011-03-25

Similar Documents

Publication Publication Date Title
AP2007004171A0 (en) Novel compounds
EP1868612A4 (en) Novel compounds
EP1868611A4 (en) Novel compounds
EP1869026A4 (en) Novel compounds
GB0503955D0 (en) Novel compounds
GB0520578D0 (en) Novel compounds
GB0500140D0 (en) Novel compounds
GB0505205D0 (en) Novel compounds
GB0504099D0 (en) Novel compounds
GB0500884D0 (en) Novel compounds
GB0504107D0 (en) Novel compounds
GB0504109D0 (en) Novel compounds
GB0504098D0 (en) Novel compounds
GB0504097D0 (en) Novel compounds
GB0504095D0 (en) Novel compounds
GB0503155D0 (en) Novel compounds
GB0503142D0 (en) Novel compounds
GB0503135D0 (en) Novel compounds
GB0503134D0 (en) Novel compounds
GB0500285D0 (en) Novel compounds
GB0503133D0 (en) Novel compounds
GB0503132D0 (en) Novel compounds
GB0503131D0 (en) Novel compounds
GB0500406D0 (en) Novel compounds
GB0503129D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)